Nancy Harrison

Board Member, Knight Therapeutics Inc.

Nancy Harrison currently serves as Director of Knight Therapeutics, Board Member of The Polygon Gallery, Board Member of adMare BioInnovations & The Centre for Drug Research & Development. Nancy is former Co-founder and President of MSI Methylation Sciences, a private venture backed development company with a novel treatment of depression in a Phase II clinical trial. She is a former Partner and Senior Vice President of Ventures West Management Inc. Nancy spent 13 years with Ventures West leading its life sciences practice in Canada and the U.S. She is one of the most experienced life sciences investors in the Canadian venture capital industry and was instrumental in Ventures West’s involvement in the sect.